Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Akiyoshi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Akiyoshi, T.

Clinical Cancer Research, Vol 2, Issue 9 1619-1625, Copyright © 1996 by American Association for Cancer Research


ARTICLES

Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma

J Li, Y Yang, T Fujie, K Baba, H Ueo, M Mori and T Akiyoshi
Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu 874, and Department of Surgery, Oita Prefectural Hospital, Oita 870, Japan.

The MAGE, BAGE, and GAGE genes code for distinct antigens that are recognized by autologous cytolytic T lymphocytes. We investigated the expression of these genes in both cell lines and surgical samples of gastric carcinoma, using reverse transcription-PCR. Furthermore, the induction of these genes by 5-aza-2'-deoxycytidine (DAC), a demethylating agent, was also examined in several cell lines. Of 11 cell lines, BAGE, GAGE1-6, GAGE1-2, MAGE-1, and MAGE-3 were detected in 7 (64%), 4 (36%), 3 (27%), 8 (73%), and 8 (73%) cell lines, respectively. After the in vitro treatment of the negative cell lines with DAC, the expression of these genes became positive in 46 to 91% of these cell lines. No expression of these genes was seen in any of the 57 samples of normal gastric tissue. In contrast, the tumor tissue samples expressed BAGE, GAGE1-6, GAGE1-2, MAGE-1, and MAGE-3 in 13 (23%), 9 (16%), 6 (11%), 25 (44%), and 23 (40%) tissue samples, respectively. Thus, at least one of these genes was expressed in 35 (61%) of 57 carcinomas. An analysis of the relationship between clinicopathological factors and the expression of these genes revealed that either BAGE or one of these genes was more frequently expressed in histologically intestinal-type than in diffuse-type carcinomas. Our results suggest that, because of the higher expression of these genes and the possible induction of these genes by DAC, patients with gastric carcinoma may, therefore, be potential candidates for tumor-specific immunotherapy directed against these antigens.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. C. D'Alessio, I. C. G. Weaver, and M. Szyf
Acetylation-Induced Transcription Is Required for Active DNA Demethylation in Methylation-Silenced Genes
Mol. Cell. Biol., November 1, 2007; 27(21): 7462 - 7474.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. O. Gure, R. Chua, B. Williamson, M. Gonen, C. A. Ferrera, S. Gnjatic, G. Ritter, A. J.G. Simpson, Y.-T. Chen, L. J. Old, et al.
Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer
Clin. Cancer Res., November 15, 2005; 11(22): 8055 - 8062.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Nishigaki, K. Aoyagi, I. Danjoh, M. Fukaya, K. Yanagihara, H. Sakamoto, T. Yoshida, and H. Sasaki
Discovery of Aberrant Expression of R-RAS by Cancer-Linked DNA Hypomethylation in Gastric Cancer Using Microarrays
Cancer Res., March 15, 2005; 65(6): 2115 - 2124.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kozar, R. Kaminski, T. Switaj, T. Oldak, E. Machaj, P. J. Wysocki, A. Mackiewicz, W. Lasek, M. Jakobisiak, and J. Golab
Interleukin 12-based Immunotherapy Improves the Antitumor Effectiveness of a Low-Dose 5-Aza-2'-Deoxycitidine Treatment in L1210 Leukemia and B16F10 Melanoma Models in Mice
Clin. Cancer Res., August 1, 2003; 9(8): 3124 - 3133.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Hippo, H. Taniguchi, S. Tsutsumi, N. Machida, J.-M. Chong, M. Fukayama, T. Kodama, and H. Aburatani
Global Gene Expression Analysis of Gastric Cancer by Oligonucleotide Microarrays
Cancer Res., January 1, 2002; 62(1): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Tahara, K. Takesako, A. Sette, E. Celis, S. Kitano, and T. Akiyoshi
Identification of a MAGE-2-encoded Human Leukocyte Antigen-A24-binding Synthetic Peptide That Induces Specific Antitumor Cytotoxic T Lymphocytes
Clin. Cancer Res., August 1, 1999; 5(8): 2236 - 2241.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Chen, S.-H. Lin, L. W. K. Chung, and R. A. Sikes
Isolation and Characterization of PAGE-1 and GAGE-7. NEW GENES EXPRESSED IN THE LNCaP PROSTATE CANCER PROGRESSION MODEL THAT SHARE HOMOLOGY WITH MELANOMA-ASSOCIATED ANTIGENS
J. Biol. Chem., July 10, 1998; 273(28): 17618 - 17625.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Eichmuller, D. Usener, R. Dummer, A. Stein, D. Thiel, and D. Schadendorf
Serological detection of cutaneous T-cell lymphoma-associated antigens
PNAS, January 16, 2001; 98(2): 629 - 634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.